enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. CRISPR Therapeutics - Wikipedia

   en.wikipedia.org/wiki/CRISPR_Therapeutics

   CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland.It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.

3. 3 Things You Need to Know if You Buy CRISPR Therapeutics Today

   www.aol.com/3-things-know-buy-crispr-144500442.html

   CRSP Market Cap data by YCharts. 3. Intensive competition. The success of CRISPR Therapeutics will depend on its ability to bring multiple new drugs to the market to support a more viable business ...

4. This Beaten-Down Biotech Stock Just Got Some Good News: Time ...

   www.aol.com/finance/beaten-down-biotech-stock...

   CRISPR Therapeutics' development of Casgevy helped validate its gene-editing platform. The company's innovative approach should yield more solid clinical and regulatory wins in the next five years.

5. CRISPR Therapeutics Provides Business Update and Reports ...

   lite.aol.com/tech/story/0022/20241105/9267676.htm

   ZUG, Switzerland and BOSTON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the third quarter ended September 30, 2024.

6. CRISPR Therapeutics Presents Data at the 2024 American ...

   lite.aol.com/tech/story/0022/20241209/9316263.htm

   ZUG, Switzerland and BOSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112™, a ...

7. Is CRISPR Therapeutics Stock a Buy? - AOL

   www.aol.com/crispr-therapeutics-stock-buy...

   As a result, CRISPR Therapeutics may soon opt to slow down its initiation of new pre-clinical programs, or (perhaps temporarily) shelve programs rather than advancing them into early stage ...

8. FDA considers first CRISPR gene editing treatment that may ...

   www.aol.com/fda-considers-first-crispr-gene...

   If approved, exa-cel, made by Boston-based Vertex Pharmaceuticals and the Swiss company CRISPR Therapeutics, would be the first FDA-approved treatment that uses genetic modification called CRISPR.

9. Mammoth Biosciences - Wikipedia

   en.wikipedia.org/wiki/Mammoth_Biosciences

   The company was founded in 2017 [3] by Jennifer Doudna, Janice Chen, and Lucas Harrington of the University of California, Berkeley, and Trevor Martin of Stanford University. [4] Mammoth signed agreements in December 2019 and January 2020 with Horizon Discovery to combine Mammoth's intellectual property in CRISPR with Horizon's expertise in ...